According to RVL Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,61ย โฌ. In 2022 the company made an earnings per share (EPS) of -0,48ย โฌ an increase over its 2021 EPS that were of -0,82ย โฌ.